OMED Health (“OMED”), a UK-based business pioneering non-invasive breath analysis for gut health and part of Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the launch of OMED Health Plans, personalized treatments and services to help patients gain control of their functional gastrointestinal (GI) conditions, a problem that affects over one billion people worldwide.